Financial

Asian Stock: Santen Pharmaceutical

- by - Leave a Comment

Company: Santen Pharmaceutical Company LimitedBloomberg ticker: 4536 JPMarket cap: US$4,532mBackground: Santen Pharmaceutical Company Limited is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries.
 World Class Benchmarking of Santen Pharmaceutical(Click on image to enlarge)

  • Profitable Growth rank of 1 was up compared to the prior period’s 2nd rank
  • This is World Class performance compared to 360 large Health Care companies worldwide
  • Profitability rank of 3 was worse than its Growth rank of 1
  • Profitability rank of 3 was the same compared to the prior period’s 3rd rank
  • This is above average performance compared to peers
  • Growth rank of 1 was up compared to the prior period’s 2nd rank
  • This is World Class performance compared to peers

    • More By This Author:Asian Stock: GoertekAustralian Stock: AGL EnergyAsian Stock: Pakuwon Jati

    Related Posts

    Goldman Q3 Profit Jumps 45% On Surge In Equity-Trading Revenue As Earnings Beat Across The Board

    Citigroup Earnings Top Estimates, Boosted By Investment Banking

    Futures Flat At All Time High As Oil Tumbles, Bank Earnings Shine

    About

    View all posts by →

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    This site uses Akismet to reduce spam. Learn how your comment data is processed.